Taurine 8 pp 287-297 | Cite as

Inhibitory Effects of Taurine on STZ-Induced Apoptosis of Pancreatic Islet Cells

  • Shumei Lin
  • Jiancheng Yang
  • Gaofeng Wu
  • Mei Liu
  • Qiufeng Lv
  • Qunhui Yang
  • Jianmin HuEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 775)


The present research aims to investigate the inhibition effect of taurine on the apoptosis of pancreatic islet cells induced by Streptozotocin (STZ). One hundred male Wistar rats weighing 180–200 g were randomly divided into two groups, rats in the experimental were intraperitoneally injected with 2% STZ (50 mg/kg bw, dissolved in 0.1 mmol/L pH 4.2 citrate buffer), rats in the control group were injected with the same volume of citrate buffer. Rats with the fasting blood glucose level higher than 16.7 mmol/L were selected and randomly divided into four groups: Rats in M group were STZ-induced diabetes rats, rats in T1, T2, and T3 groups were intragastrically administered with taurine (dissolved in 0.5% sodium carboxymethyl cellulose as thickening agent) once a day for 4 weeks with the contents of 0.6 g/kg, 1.2 g/kg, and 2.4 g/kg bw, respectively, while rats in group C and M were given the same amount of thickening agent as T2 group. Four weeks later, pancreatic tissues were fixed and processed for paraffin section. The results showed that STZ induced a significant increase in apoptotic rate of pancreatic islet cells, up-regulated the expression of bax and Fas and down-regulated the expression of Bcl-2, which were significantly blocked by taurine (P < 0.05). The results indicated that taurine could significantly restrain apoptosis of pancreatic islet cells induced by STZ.


Islet Cell Integral Optical Density Pancreatic Islet Cell Taurine Supplementation Pancreatic Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.








Financial support from the National Research Foundation of China (Project no. 30972154) and Doctoral initiaitng project of liaoning province (Project no. 20111083) is acknowledged.


  1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRefGoogle Scholar
  2. Eizirik DL, Strandell E, Sandler S (1988) Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia 31:168–174PubMedCrossRefGoogle Scholar
  3. Garchon HJ, Luan JJ, Eloy L, Bédossa P, Bach JF (1994) Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 24(2):380–384PubMedCrossRefGoogle Scholar
  4. Hanke J (2000) Apoptosis and occurrence of Bcl-2, Bak, Bax Fas and FasL in the developing and adult rat endocrine pancreas. Anat Embryol 202:303–312PubMedCrossRefGoogle Scholar
  5. Hoorens A, Pipeleers D (1999) Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis. Diabetologia 42:55–59PubMedCrossRefGoogle Scholar
  6. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72(1):101–163PubMedGoogle Scholar
  7. Kase BF, Prydz K, Björkhem I et al (1986) Conjugation of cholic acid with taurine and glycine by rat liver peroxisomes. Biochem Biophys Res Commun 138(1):167–173PubMedCrossRefGoogle Scholar
  8. Kim YH, Kim S, Kim KA, Yagita H, Kayagaki N, Kim KW, Lee MS (1999) Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455–465PubMedCrossRefGoogle Scholar
  9. Kuriyama K (1980) Taurine as a neuromodulator. Fed Proc 39(9):2680–2684PubMedCrossRefGoogle Scholar
  10. Kurrer MO, Pakala SV, Hanson HL, Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213–218PubMedCrossRefGoogle Scholar
  11. Lee MS, Kim S, Chung JH, Lee MK, Kim KW (1999) Fas is expressed in murine pancreatic islet cells and an insulinoma cell line but does not mediate their apoptosis in vitro. Autoimmunity 29(3):189–199PubMedCrossRefGoogle Scholar
  12. Liu D, Cardozo AK, Darville MI, Eizirik DL (2002) Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 143:1225–1234PubMedCrossRefGoogle Scholar
  13. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY (2001) Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50:69–76PubMedCrossRefGoogle Scholar
  14. Maher SG, Condron CEM, Bouchier-Hayes DJ, Toomey DM (2005) Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin Exp Immunol 139(2):279–286PubMedCrossRefGoogle Scholar
  15. Mansford KR, Opie L (1968) Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1(7544):670–671PubMedCrossRefGoogle Scholar
  16. Molchanova SM, Oja SS, Saransaari P (2005) Mechanisms of enhanced taurine release under Ca2+ depletion. Neurochem Int 47(5):343–349PubMedCrossRefGoogle Scholar
  17. Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M (2005) Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 20(6):278–285PubMedCrossRefGoogle Scholar
  18. Ozasa H, Gould KG (1982) Protective effect of taurine from osmotic stress on chimpanzee spermatozoa. Arch Androl 9(2):121–126PubMedCrossRefGoogle Scholar
  19. Park E, Jia J, Quinn MR et al (2002) Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 102(2):179–184PubMedCrossRefGoogle Scholar
  20. Redmond HP, Wang JH, Bouchier-Hayes D (1996) Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 131:1280–1287PubMedCrossRefGoogle Scholar
  21. Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22(4):485–518PubMedGoogle Scholar
  22. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo Monte A, Buscemi G, Galluzzo A, Giordano C (1995) Expression of apoptosis-inducing CD95 (Fas/Apo 1) on human beta-cells sorted by flow cytometry and cultured in vitro. Transplant Proc 27:3271–3275PubMedGoogle Scholar
  23. Stennicke HR, Salvesen GS (2000) Caspases – controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 1477(1–2):299–306PubMedCrossRefGoogle Scholar
  24. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:536–546Google Scholar
  25. Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y, Azuma J (2004) Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol 287:C949–C953PubMedCrossRefGoogle Scholar
  26. Taranukhin AG, Taranukhina EY, Saransaari P, Pelto-Huikko M, Podkletnova M, Oja S (2012) Taurine protects cerebellar neurons of the external granular layer against ethanol-induced apoptosis in 7-day-old mice. Amino Acids. doi:10.1007/s00726-012-1254-6Google Scholar
  27. Thomas HE, Darwiche R, Corbett JA, Kay TW (2002) Interleukin-1 plus-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 51:311–316PubMedCrossRefGoogle Scholar
  28. Tong L, Li J, Qiao H et al (2006) Taurine protects against ischemia-reperfusion injury in rabbit livers. Transplant Proc 38(5):1575–1579PubMedCrossRefGoogle Scholar
  29. Vavra JJ, Deboer C, Dietz A, Hanka LJ, Sokolski WT (1959) “Streptozotocin, a new antibacterial antibiotic”. Antibiot Annu 7:230–235PubMedGoogle Scholar
  30. Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, Deferrari G (2002) Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 50(6):443–451PubMedCrossRefGoogle Scholar
  31. Wada R, Yagihashi S (2004) Nitric oxide generation and poly(ADP ribose) polymerase activation precede beta-cell death in rats with a single high-dose injection of streptozotocin. Virchows Arch 444:375–382PubMedCrossRefGoogle Scholar
  32. Wang JH, Redmond HP, Watson RW, Condron C, Bouchier-Hayes D (1996) The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 6:331–338PubMedCrossRefGoogle Scholar
  33. Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D (1999) Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277:C1229–C1238PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Shumei Lin
    • 1
  • Jiancheng Yang
    • 1
  • Gaofeng Wu
    • 1
  • Mei Liu
    • 1
  • Qiufeng Lv
    • 1
  • Qunhui Yang
    • 1
  • Jianmin Hu
    • 1
    Email author
  1. 1.College of Animal Science & Veterinary MedicineShenyang Agricultural UniversityShenyangP.R. China

Personalised recommendations